Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Aptuit Paying $64M For Evotec Chemistry Unit

Sep. 12, 2007

By Cormac Sheridan

Aptuit Paying $64M For Evotec Chemistry Unit

Sep. 12, 2007

By Cormac Sheridan

MediGene Gets $21M In Private Share Placement

Sep. 12, 2007

By Cormac Sheridan

FDA OKs TopoTarget's Totect For Extravasation Treatment

Sep. 12, 2007

By Cormac Sheridan

Aptuit Paying $64M For Evotec Chemistry Unit

Sep. 12, 2007

By Cormac Sheridan

Aptuit Paying $64M For Evotec Chemistry Unit

Sep. 12, 2007

By Cormac Sheridan

FDA OKs TopoTarget's Totect For Extravasation Treatment

Sep. 12, 2007

By Cormac Sheridan

MediGene Gets $21M In Private Share Placement

Sep. 12, 2007

By Cormac Sheridan

Forest Terminates Interest In Paion's Desmoteplase

Sep. 5, 2007

By Cormac Sheridan

Jerini Goes Solo With Icatibant In U.S. As Abbott Walks Out

Sep. 5, 2007

By Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...